Atorvastatin for unruptured intracranial vertebrobasilar dissecting aneurysm (ATREAT-VBD): protocol for a randomised, double-blind, blank-controlled trial

INTRODUCTION: Vertebrobasilar dissecting aneurysms (VBDAs) are associated with serious complications and a poor prognosis. It is believed that inflammation of the aneurysm wall may be the main cause of rupture or deterioration. Atorvastatin has been shown to inhibit inflammation and may be a suitabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Turhon, Mirzat, Kang, Huibin, Huang, Jiliang, Li, Mengxing, Liu, Jian, Zhang, Ying, Wang, Kun, Yang, Xinjian, Zhang, Yisen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052054/
https://www.ncbi.nlm.nih.gov/pubmed/35487525
http://dx.doi.org/10.1136/bmjopen-2021-059616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052054/
https://www.ncbi.nlm.nih.gov/pubmed/35487525
http://dx.doi.org/10.1136/bmjopen-2021-059616

Ejemplares similares